Rocket One Inc. Investment Income, Interest
Rocket One Inc. (RKTO) reported Investment Income, Interest of $149 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- Rocket One Inc. investment income, interest for the quarter ending 2026-06-30 was $149.00, a 13.87% decline year-over-year.
- Rocket One Inc. investment income, interest for the quarter ending 2025-06-30 was $173.00.
- Rocket One Inc. investment income, interest for fiscal 2023 was $781.00, a 87.74% decline from fiscal 2022.
- Rocket One Inc. investment income, interest for fiscal 2022 was $6.37K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 12 month |
|---|---|---|---|
| 2026-06-30 | $149.00 10-Q · filed 2026-08-14 | $298.00 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $173.00 10-Q · filed 2026-08-14 | $354.00 10-Q · filed 2026-08-14 | |
| 2023-12-31 | $781.00 10-K · filed 2024-03-28 | ||
| 2022-12-31 | $6.37K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |